HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print August 28, 2007

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0307183v1 82/6/1393    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bryson, J. S. Articles by Kaplan, A. M. Search for Related Content PubMed PubMed Citation Articles by Bryson, J. S. Articles by Kaplan, A. M.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0307183

Received for publication March 20, 2007.
Revised August 2, 2007.
Accepted for publication August 6, 2007.

Article

Adoptive transfer of murine syngeneic graft-vs.-host disease by CD4⁺ T cells

J. Scott Bryson ^*||@, C. Darrell Jennings ^||, Jason A. Brandon , Jacqueline Perez , Betty E. Caywood ^*, and Alan M. Kaplan ^||

*Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Internal Medicine;Department of Microbiology, Immunology and Molecular Genetics, Department of Pathology and Laboratory Medicine; and Graduate Center for Toxicology and ||Lucille Parker Markey Cancer Center, University of Kentucky Medical Center, University of Kentucky, Lexington, Kentucky, USA

^@ To whom correspondence should be addressed. E-mail: jsbrys{at}uky.edu.

	Abstract

Syngeneic graft-vs.-host disease (SGVHD) develops in rodents following the treatment of lethally irradiated, bone marrow (BM) reconstituted animals with a short course of the immunosuppressive agent cyclosporine A (CsA). Using an in vivo depletion approach, we recently demonstrated that CD4⁺, but not CD8⁺, T cells participated in inducing SGVHD. Studies were therefore undertaken to adoptively transfer SGVHD into lethally irradiated, syngeneic BM reconstituted secondary recipients. Whole T cell populations as well as purified CD4⁺T cells isolated from SGVHD, but not normal or transplant control, animals mediated the transfer of SGVHD into secondary recipients. These cells have an apparent specificity for enteric bacterial antigens. The pathologic process that developed was identical to that observed in the animals with de novo SGVHD after syngeneic BMT and CsA therapy. It was shown that a radiation-sensitive mechanism prevented the transfer of SGVHD into normal, nonirradiated secondary recipients. The ability to reproducibly transfer SGVHD into secondary recipients will enhance our ability to study regulatory mechanisms that are altered during CsA therapy and permit the development of murine CsA-induced SGVHD.

Key Words: bone marrow transplantation • SGVHD • lymphoid cells • T cell proliferation • dendritic cells